In short: Referenced only — the second partner (with Tempus) in AZN's oncology foundation-model effort; named as part of AZN's "direct investment in the data infrastructure that could compress drug discovery timelines." No view expressed.
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.